🔄 Less for... Less. CVS drops Zepbound
Why go with the less effective medicine? The answer won't surprise you at all.
CVS Health is the closest pharmacy for many and it’s dropping coverage in it’s formulary for Zepbound, and choosing Wegovy as it’s preferred GLP1 Receptor Agonist.
Wegovy (Semaglutide) is good, but Zepbound (Tirzepatide) is better for weight loss, and that’s been shown in research trials at this point.
CVS is referring to this development as “Improving access and affordability to high-cost weight management drugs”, but it’s going to do the opposite, if you consider quality and… the current status quo.
Keep reading with a 7-day free trial
Subscribe to GLP1 Guide to keep reading this post and get 7 days of free access to the full post archives.